The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...
Woman's World on MSN
Normal AST levels by age: Are you at risk of fatty liver disease?
A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...
While liver stiffness measurement by vibration-controlled transient elastography with a 25 kPa threshold might detect CSPH, the overall low quality of the studies means that these results are not very ...
A high-fat diet does more than overload the liver with fat. New research from MIT shows that prolonged exposure to fatty ...
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and improve hepatic vascular function in cirrhosis. The ...
As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as quickly, making people more susceptible to a variety of infections. To try to ...
HONOLULU (KHON) — What does a healthy liver look like? The University of Hawaii John A. Burns School of Medicine is offering free liver testing for the public to join their liver health study. “This ...
WASHINGTON -- An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting early hepatocellular carcinoma (HCC), according to a ...
Yes, your liver helps your body process that glass of wine you had with dinner last night, but it also does so much more. “The liver works hard daily to metabolize nutrients, filter out toxins, and ...
(RTTNews) - Exact Sciences Corp. (EXAS), Friday announced the landmark clinical results from its ALTUS study, showing that the Oncoguard Liver blood test significantly outperforms ultrasound in ...
ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups Exact Sciences Corp.
The FDA has halted clinical testing of an Intellia Therapeutics gene-editing therapy following a report that a patient in a Phase 3 study was hospitalized with liver complications. Intellia said the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback